Paxeladine Syrup 2mg/ml, 100ml + teaspoon/dosage measure, Ipsen

Symptomatic treatment for dry and irritating cough.

Properties:

Clear syrup, faint yellow in color, with chocolate and cherry flavor.
It is recommended for upper respiratory tract infections: flu, throat, measles, whooping cough; tracheitis, tracheobronchitis, nasopharyngitis, laryngitis, spasmodic and reflex cough, irritative cough, ENT syndromes.
It is suitable for adults, children over 30 months of age and weighing over 15 kg.
The package contains a measuring spoon with graduations of 2.5 ml and 5 ml or a measuring measure of 2.5 ml and 5 ml.

Composition:

A bottle with 100ml syrup contains 0.2 g oxeladine citrate; 2.5ml syrup contains 5 mg oxeladine citrate; 5ml syrup contains 10 mg oxeladine citrate.

Excipients with known effect: 2.5ml of syrup contains 2.125g of sugar and 5ml of syrup contains 4.25g of sugar.

Paxeladine 2mg/ml syrup contains ethanol 12 mg/2.5 ml and 24 mg/5 ml.

Method of administration:

30 months – 6 years (15-20 kg): 2.5 ml/4 hours, max 3-4 x/day
6-10 years (20-30 kg): 5 ml/4 hours, max 2-3 x/day
10-15 years (30-50 kg): 5 ml/4 hours, max 3-5 x/day
Adults: 5 ml/4 hours, max 5 x/day
Dosing measure with graduations: 2.5ml = 5mg; 5ml = 10mg
Warnings:

Productive cough, which is a basic feature of the bronchopulmonary defenses, must be respected. It is not recommended to combine an expectorant or mucolytic agent with an antitussive, as it does not bring therapeutic benefits.
It is recommended to investigate the etiology of the cough that will require specific treatment before prescribing a cough suppressant. If the cough proves refractory to the recommended doses of antitussive, the dose is not increased, but the clinical situation is reassessed.

Precautions: Patients with diabetes mellitus or with a low–carbohydrate diet should consider the sugar content: 4.25 g sugar/ 5 ml, respectively 2.125 g sugar/ 2.5 ml. As there are insufficient data on the efficacy and safety of this medicine in children under 30 months of age, it is not recommended for use until this age.

Interactions with other medicinal products and other forms of interaction: To date, no interactions with other medicinal products have been reported.

Fertility, pregnancy and breastfeeding:

Pregnancy: There are no conclusive data on teratogenicity in animals. To date, no teratogenic or fetotoxic effects have been clinically observed. However, studies of exposure to oxeladine citrate during pregnancy are not sufficient to exclude any risk. Therefore, it is not recommended to use this drug during pregnancy.

Breast–feeding: As there is insufficient data on the passage of the drug into milk, it is not recommended to use it during breastfeeding.
Effects on the ability to drive and use machines: It does not affect the ability to drive or use machines.

Presentation form: Bottle with 100ml + teaspoon/dosage measure